Artificial intelligence is increasingly used to predict patient conditions, aid diagnosis and suggest treatments, prompting hospitals to examine not just performance but also accountability and safety.
International guidance highlights accountability
The Seoul Declaration on AI Healthcare, unveiled at the World Bio Summit 2026, urges expansion of AI based on proven clinical effectiveness and safety, with risk-based oversight throughout a system’s life cycle and preservation of human judgment in final decisions.
During the summit’s Leaders’ Dialogue, KAIST Professor Ye Jong-chul called for a shift from judging single AI models to ensuring the reliability of whole clinical workflows, stressing the need for rules on tool selection, required human approvals, and clear accountability records when multiple AI agents interact.
Hospital responsibilities for AI deployment
Hospitals are expected to define permissible AI functions, conduct risk assessments before rollout, and continuously monitor performance and errors once the tools are active.
Any change in patient demographics, clinical pathways, or model updates should trigger a fresh risk review, according to the guidance.
Institutions must also be able to trace why clinicians accepted, altered, or rejected AI recommendations, and document the actions taken when issues arise.
Consider a hospital that implements an AI system to forecast patient deterioration; the technology’s predictive score alone does not guarantee benefit.
The workflow following an alert becomes critical: the hospital must designate who receives the warning, set a response time, identify backup clinicians if the primary responder is unavailable, and adjust alert thresholds when excessive warnings cause fatigue or bias toward specific patient groups.
Clear role definitions are essential. Clinical departments oversee patient-facing use and outcomes, while IT and data teams ensure system stability and data integrity. Safety, quality improvement, legal and other support units jointly evaluate risks, and senior management resolves any inter-departmental conflicts and allocates resources.
These internal controls create a unified accountability framework, allowing clinicians to concentrate on patient care while relying on structured AI support.
Regulatory and audit considerations
Government agencies and regulators play a complementary part, setting evidence standards and outlining required reviews at each stage—from development and validation to deployment and ongoing operation.
Transparent evaluation criteria, predefined thresholds for reassessment after major changes, and clear incident-reporting procedures can reduce uncertainty for hospitals and speed responsible innovation.
Support mechanisms, such as validation tools and clinician training programs, are also recommended to help institutions meet regulatory expectations.
Internal audit functions must adapt, keeping responsibility for AI oversight with management and relevant departments while auditors independently verify that risk assessments, approval processes and incident responses are adequate.
Auditors need sufficient knowledge of clinical practice to spot accountability gaps that may arise when duties are spread across multiple teams.
When audit findings feed back into future deployments, organizations can learn from experience and improve safety.
Building an assurance framework
The proposed assurance framework would link technical validation, hospital operational controls and independent evaluation, documenting what was checked, which standards applied and the evidence supporting each conclusion.
From the moment a hospital decides to adopt AI, it must set usage conditions, assign responsibility and refine controls based on evidence gathered during real-world use.